162 related articles for article (PubMed ID: 12638020)
1. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease.
Brockmann K; Dechent P; Meins M; Haupt M; Sperner J; Stephani U; Frahm J; Hanefeld F
J Neurol; 2003 Mar; 250(3):300-6. PubMed ID: 12638020
[TBL] [Abstract][Full Text] [Related]
2. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.
Brockmann K; Dechent P; Wilken B; Rusch O; Frahm J; Hanefeld F
Neurology; 2003 Mar; 60(5):819-25. PubMed ID: 12629240
[TBL] [Abstract][Full Text] [Related]
3. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
5. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.
Kruse B; Hanefeld F; Christen HJ; Bruhn H; Michaelis T; Hänicke W; Frahm J
J Neurol; 1993 Dec; 241(2):68-74. PubMed ID: 7908027
[TBL] [Abstract][Full Text] [Related]
6. Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter.
van der Voorn JP; Pouwels PJ; Salomons GS; Barkhof F; van der Knaap MS
Neuroradiology; 2009 Oct; 51(10):669-75. PubMed ID: 19484233
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy and magnetic resonance imaging findings in Krabbe's disease.
Zarifi MK; Tzika AA; Astrakas LG; Poussaint TY; Anthony DC; Darras BT
J Child Neurol; 2001 Jul; 16(7):522-6. PubMed ID: 11453451
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of the brain in a patient with L-2-hydroxyglutaric acidemia.
Hanefeld F; Kruse B; Bruhn H; Frahm J
Pediatr Res; 1994 May; 35(5):614-6. PubMed ID: 8065847
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
10. Infantile Alexander disease: a GFAP mutation in monozygotic twins and novel mutations in two other patients.
Meins M; Brockmann K; Yadav S; Haupt M; Sperner J; Stephani U; Hanefeld F
Neuropediatrics; 2002 Aug; 33(4):194-8. PubMed ID: 12368989
[TBL] [Abstract][Full Text] [Related]
11. Cerebral proton magnetic resonance spectroscopy of a patient with giant axonal neuropathy.
Brockmann K; Pouwels PJ; Dechent P; Flanigan KM; Frahm J; Hanefeld F
Brain Dev; 2003 Jan; 25(1):45-50. PubMed ID: 12536033
[TBL] [Abstract][Full Text] [Related]
12. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.
Pouwels PJ; Brockmann K; Kruse B; Wilken B; Wick M; Hanefeld F; Frahm J
Pediatr Res; 1999 Oct; 46(4):474-85. PubMed ID: 10509371
[TBL] [Abstract][Full Text] [Related]
13. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.
Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T
Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy reveals lactate in infantile neuroaxonal dystrophy (INAD).
Mader I; Krägeloh-Mann I; Seeger U; Bornemann A; Nägele T; Küker W; Grodd W
Neuropediatrics; 2001 Apr; 32(2):97-100. PubMed ID: 11414651
[TBL] [Abstract][Full Text] [Related]
15. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
[TBL] [Abstract][Full Text] [Related]
16. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis.
Seitz D; Grodd W; Schwab A; Seeger U; Klose U; Nägele T
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1373-7. PubMed ID: 9726485
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy.
Pouwels PJ; Kruse B; Korenke GC; Mao X; Hanefeld FA; Frahm J
Neuropediatrics; 1998 Oct; 29(5):254-64. PubMed ID: 9810561
[TBL] [Abstract][Full Text] [Related]
19. Proton MRS of a child with Sandhoff disease reveals elevated brain hexosamine.
Wilken B; Dechent P; Hanefeld F; Frahm J
Eur J Paediatr Neurol; 2008 Jan; 12(1):56-60. PubMed ID: 17625939
[TBL] [Abstract][Full Text] [Related]
20. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities.
Kristjánsdóttir R; Uvebrant P; Rosengren L
Neuropediatrics; 2001 Dec; 32(6):307-12. PubMed ID: 11870586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
